Lei Feng

Lei Feng is a High Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on oncology, hematological malignancies, lymphoid neoplasia, and cancer immunotherapy, with a specific emphasis on advancing treatment strategies for hematologic cancers. His recent work explores novel therapeutic approaches, including mitochondrial transplantation for disease treatment and the potential of targeting gut microbiota for hypertension intervention. He has also contributed to studies on cognitive aging, cardiovascular risk stratification, and clinical trials for EGFR-mutant non-small cell lung cancer. His extensive publication record spans high-impact journals such as Cell Metabolism, Annals of Oncology, and MedComm, reflecting his broad interdisciplinary collaborations in cancer research and translational medicine.